Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 19/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 19/20 | 1.00 |
| ▸ | HTR1A | P08908 | 18/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 11/20 | 1.00 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4013368 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A4HTR1ASLC6A3PDE10A | |
| Hydrochloric Acid SCHEMBL4007236 | 0.99 | SLC6A2 (0.97) | SLC6A2SLC6A4HTR1ASLC6A3PDE10A | |
| SCHEMBL13770271 | 0.87 | HTR1A (0.78) | SLC6A2SLC6A4HTR1ASLC6A3PDE10A | |
| Hydrochloric Acid SCHEMBL4005980 | 0.83 | HTR1A (0.70) | SLC6A2SLC6A4HTR1ASLC6A3PDE10A | |
| SCHEMBL7914654 | 0.83 | HTR1A (0.70) | SLC6A2SLC6A4HTR1ASLC6A3PDE10A | |
| SCHEMBL13769759 | 0.81 | HTR1A (1.00) | SLC6A2SLC6A4HTR1ASLC6A3 | |
| SCHEMBL13769617 | 0.81 | HTR1A (1.00) | SLC6A2SLC6A4HTR1ASLC6A3 | |
| Hydrochloric Acid SCHEMBL4007582 | 0.81 | HTR1A (0.97) | SLC6A2SLC6A4HTR1ASLC6A3 | |
| SCHEMBL26106128 | 0.80 | HTR1A (0.67) | SLC6A2SLC6A4HTR1ASLC6A3PDE10A | |
| SCHEMBL7495157 | 0.80 | HTR1A (0.74) | SLC6A2SLC6A4HTR1ASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |